v3.25.2
Discontinued Operations - Sale of Infusionz to Bloomios (Details 1) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Jun. 30, 2024
Jun. 30, 2023
Operating expense $ 5,146,339 $ 6,305,855 $ 13,458,877 $ 20,359,116 $ 35,287,018 $ 33,300,703
Discontinued Operations [Member]            
Operating expense         652,891  
Management fees         685,600  
Advance for payroll         50,000  
Excess working capital         388,565  
Accrued interest         247,885  
Subtotal due from Bloomios         2,024,941  
Reserve         1,179,498  
Total amounts due from Bloomios         $ 845,443